NKTR-118
D3820C00006
Phase 3 small_molecule terminated
Quick answer
NKTR-118 for Opioid-Induced Constipation is a Phase 3 program (small_molecule) at AstraZeneca with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca
- Indication
- Opioid-Induced Constipation
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated